Piper Sandler Maintains Neutral on Exact Sciences, Raises Price Target to $70
Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and raises the price target from $50 to $70.
Exact Sciences Q4 EPS $(0.72) Beats $(0.84) Estimate, Sales $553.00M Beat $528.22M Estimate
Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.84) by 14.29 percent. This is a 43.75 percent increase over losses of $(1.28) per share from
Earnings Scheduled For February 21, 2023
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is likely to report earnings for its fourth quarter.
Cathie Wood Bulks Up On Shopify Amid Stock’s 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week
Cathie Wood’s Ark Invest reversed its stance on Canadian e-commerce retailer Shopify, Inc. (NYSE: SHOP) and began bulking up on the stock this week.
The Latest Analyst Ratings for Exact Sciences
Analysts have provided the following ratings for Exact Sciences (NASDAQ:EXAS) within the last quarter: Bullish Somewhat Bullish Indifferent…
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ:
‘I Think You Should Take The Money And Run’: Cramer On This Stock Up 52% Over Past Month
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec.
Don’t Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.
Bulls And Bears Of The Week: Tesla, Apple, Microsoft And Dogecoin Millionaire’s Plan To Buy More Cardano
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest’s Flagship Fund, Catapulting Past Zoom, Tesla
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.